Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001378325-26-000013
Filing Date
2026-04-28
Accepted
2026-04-28 12:39:08
Documents
18
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A cv-20260427.htm   iXBRL DEF 14A 1039233
3 cv-20260427_g1.jpg GRAPHIC 11138
4 cv-20260427_g2.jpg GRAPHIC 9230
5 cv-20260427_g3.jpg GRAPHIC 4702
6 cv-20260427_g4.jpg GRAPHIC 7730
7 cv-20260427_g5.jpg GRAPHIC 548083
8 cv-20260427_g6.jpg GRAPHIC 3923394
9 cv-20260427_g7.jpg GRAPHIC 177372
  Complete submission text file 0001378325-26-000013.txt   12921787

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cv-20260427.xsd EX-101.SCH 920
21 EXTRACTED XBRL INSTANCE DOCUMENT cv-20260427_htm.xml XML 1208
Mailing Address 18805 COX AVENUE SUITE 250 SARATOGA CA 95070
Business Address 18805 COX AVENUE SUITE 250 SARATOGA CA 95070 (408) 370-4790
CapsoVision, Inc (Filer) CIK: 0001378325 (see all company filings)

EIN.: 203369494 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42705 | Film No.: 26905706
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)